CLINICAL OUTCOMES OF PATIENTS WITH ENDOPHTHALMITIS AFTER DEXAMETHASONE INTRAVITREAL IMPLANT-Reference-Cited by-同舟云学术

CLINICAL OUTCOMES OF PATIENTS WITH ENDOPHTHALMITIS AFTER DEXAMETHASONE INTRAVITREAL IMPLANT

Published:2022-10 Issue:10 Volume:42 Page:1915-1920
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Samuelson Annika G.,Nahar Ankur,Patel Samir N.,Mahmoudzadeh Raziyeh,Salabati Mirataollah,Yu-Chuan Kang Eugene,Hinkle John W.,Soares Rebecca R.,Kuriyan Ajay E.,Garg Sunir J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference19 articles.

1. Intravitreal dexamethasone implants for refractory macular edema in eyes with noninfectious uveitis;Kang;J Clin Med,2021

2. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema;He;BMC Ophthalmol,2018

3. Reliability and safety of intravitreal ozurdex injections. The ZERO study [in German];Schmitz;Ophthalmologe,2014

4. Incidence and visual outcomes of culture-proven endophthalmitis following dexamethasone intravitreal implant;Stem;JAMA Ophthalmol,2017

5. Acute bacterial endophthalmitis following dexamethasone intravitreal implant: a case report;Al Zamil;Saudi J Med Med Sci,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of dexamethasone implants in uveitis treatment;Frontiers in Medicine;2024-06-28

2. CLINICAL OUTCOMES OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL DELIVERY OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS VERSUS STEROIDS;Retina;2023-06

3. Dexamethasone;Reactions Weekly;2023-01-07